Related Experiment Video
Updated: Dec 13, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6
Cheemala Ashok1, Murugan Selvam1, Saravanaraman Ponne1
1Department of Biotechnology, Pondicherry Central University, R. V. Nagar, Kalapet, Pondicherry, 605014, India.
Abstract:
CREB signaling is known for several decades, but how it regulates both positive and negative regulators of cell proliferation is not well understood. On the other hand functions of major epigenetic repressors such as DNMT3B, EZH2 and CUL4B for their repressive epigenetic modifications on chromatin have also been well studied. However, there is very limited information available on how these repressors are regulated at their transcriptional level. Here, using computational tools and molecular techniques including site directed mutagenesis, promoter reporter assay, chromatin immunoprecipitation (ChIP), we identified that CREB acts as a common transcription factor for DNMT3B, EZH2, CUL4B and E2F6. ChIP assay revealed that pCREB binds to promoters of these repressors at CREs and induce their transcription. As expected, the expression of these repressors and their associated repressive marks particularly H3K27me3 and H2AK119ub are increased and decreased upon CREB overexpression and knock-down conditions respectively in the cancer cells indicating that CREB regulates the functions of these repressors by activating their transcription. Since CREB and these epigenetic repressors are overexpressed in various cancer types, our findings showed the molecular relationship between them and indicate that CREB is an important therapeutic target for cancer therapy.
Insights
The study reveals that CREB transcription factor activates key epigenetic repressors like DNMT3B, EZH2, and CUL4B. This finding highlights CREB as a potential therapeutic target in cancer due to its role in regulating these repressors.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- CREB signaling's role in cell proliferation is known, but its regulation of positive and negative regulators is unclear.
- Epigenetic repressors (DNMT3B, EZH2, CUL4B) and their chromatin modification functions are well-studied.
- Transcriptional regulation of these major epigenetic repressors remains poorly understood.
Purpose of the Study:
- To investigate the transcriptional regulation of epigenetic repressors by CREB.
- To identify CREB as a potential common transcription factor for DNMT3B, EZH2, CUL4B, and E2F6.
- To establish the molecular link between CREB and epigenetic repressors in cancer cells.
Main Methods:
- Computational tools and molecular techniques were employed.
- Site-directed mutagenesis, promoter reporter assays, and chromatin immunoprecipitation (ChIP) were utilized.
- pCREB binding to CREs in the promoters of target genes was confirmed via ChIP.
Main Results:
- CREB was identified as a common transcription factor for DNMT3B, EZH2, CUL4B, and E2F6.
- pCREB binding to CREs on the promoters of these repressors was demonstrated, inducing their transcription.
- CREB overexpression increased repressor expression and associated marks (H3K27me3, H2AK119ub), while knockdown decreased them in cancer cells.
Conclusions:
- CREB transcriptionally activates major epigenetic repressors, including DNMT3B, EZH2, and CUL4B.
- The study establishes a molecular relationship between CREB and these epigenetic repressors.
- CREB's role in regulating these repressors suggests it is a significant therapeutic target for various cancers.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Co-activators and Co-repressors
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

